These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18564791)

  • 41. Mutations in RYR1 in malignant hyperthermia and central core disease.
    Robinson R; Carpenter D; Shaw MA; Halsall J; Hopkins P
    Hum Mutat; 2006 Oct; 27(10):977-89. PubMed ID: 16917943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?
    Robinson RL; Anetseder MJ; Brancadoro V; van Broekhoven C; Carsana A; Censier K; Fortunato G; Girard T; Heytens L; Hopkins PM; Jurkat-Rott K; Klinger W; Kozak-Ribbens G; Krivosic R; Monnier N; Nivoche Y; Olthoff D; Rueffert H; Sorrentino V; Tegazzin V; Mueller CR
    Eur J Hum Genet; 2003 Apr; 11(4):342-8. PubMed ID: 12700608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statins alter intracellular calcium homeostasis in malignant hyperthermia susceptible individuals.
    Metterlein T; Schuster F; Tadda L; Hager M; Roewer N; Anetseder M
    Cardiovasc Ther; 2010 Dec; 28(6):356-60. PubMed ID: 20955541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic variation in RYR1 and malignant hyperthermia phenotypes.
    Carpenter D; Robinson RL; Quinnell RJ; Ringrose C; Hogg M; Casson F; Booms P; Iles DE; Halsall PJ; Steele DS; Shaw MA; Hopkins PM
    Br J Anaesth; 2009 Oct; 103(4):538-48. PubMed ID: 19648156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple interacting gene products may influence susceptibility to malignant hyperthermia.
    Robinson RL; Curran JL; Ellis FR; Halsall PJ; Hall WJ; Hopkins PM; Iles DE; West SP; Shaw MA
    Ann Hum Genet; 2000 Jul; 64(Pt 4):307-20. PubMed ID: 11415515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current data on the screening of malignant hyperthermia during anesthesia].
    Krivosic-Horber R; Adnet P
    Chirurgie; 1993-1994; 119(1-2):55-8. PubMed ID: 7995103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Malignant hyperthermia--update 2002].
    Fiege M; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jul; 38(7):478-82. PubMed ID: 12822121
    [No Abstract]   [Full Text] [Related]  

  • 48. Genotype-Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel.
    Murayama T; Kurebayashi N; Ogawa H; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
    Hum Mutat; 2016 Nov; 37(11):1231-1241. PubMed ID: 27586648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case of discordance between genotype and phenotype in a malignant hyperthermia family.
    Fortunato G; Carsana A; Tinto N; Brancadoro V; Canfora G; Salvatore F
    Eur J Hum Genet; 1999; 7(4):415-20. PubMed ID: 10352931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continued progress in understanding the molecular genetics of malignant hyperthermia.
    Rosenberg H
    Can J Anaesth; 2011 Jun; 58(6):489-93. PubMed ID: 21455644
    [No Abstract]   [Full Text] [Related]  

  • 51. The genetics of malignant hyperthermia: evidence for heterogeneity.
    McPherson E; Taylor CA
    Am J Med Genet; 1982 Mar; 11(3):273-85. PubMed ID: 7081293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Malignant hyperthermia as a complication of anesthesia: predisposition is hereditary].
    Snoeck MM; Gielen MJ; Sengers RC; Padberg GW; Iles DE; Booij LH
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):616-9. PubMed ID: 9190536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Malignant hyperthermia].
    Metterlein T; Schuster F; Graf BM; Anetseder M
    Anaesthesist; 2014 Dec; 63(12):908-18. PubMed ID: 25384957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent developments in the molecular genetics of malignant hyperthermia: implications for future diagnosis at the DNA level.
    McCarthy TV; Healy JM; Lehane M; Heffron JJ
    Acta Anaesthesiol Belg; 1990; 41(2):107-12. PubMed ID: 1973552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Congenital ptosis, scoliosis, and malignant hyperthermia susceptibility in siblings with recessive RYR1 mutations.
    AlBakri A; Karaoui M; Alkuraya FS; Khan AO
    J AAPOS; 2015 Dec; 19(6):577-9. PubMed ID: 26691049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current diagnostic methods of malignant hyperthermia: an evaluation.
    Ording H
    Acta Anaesthesiol Belg; 1990; 41(2):103-6. PubMed ID: 2371801
    [No Abstract]   [Full Text] [Related]  

  • 57. Genetics and susceptibility to malignant hyperthermia.
    Anderson-Pompa K; Foster A; Parker L; Wilks L; Cheek DJ; Mill TD; Dore M; McSherry G
    Crit Care Nurse; 2008 Dec; 28(6):32-6; quiz 37. PubMed ID: 19047693
    [No Abstract]   [Full Text] [Related]  

  • 58. [Neurological aspects of malignant hyperthermia. Clinics, physiopathology, genetics].
    Serratrice G; Kozak-Ribbens G; Cozzone PJ
    Rev Neurol (Paris); 1997 Jun; 153(5):304-13. PubMed ID: 9296164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Yearly report of the European Group of Malignant Hyperthermia"].
    Kozak-Ribbens G
    Ann Fr Anesth Reanim; 1991; 10(6):606-7. PubMed ID: 1785718
    [No Abstract]   [Full Text] [Related]  

  • 60. Management of malignant hyperthermia in France: Current organisation.
    Julien Marsollier F; Roux-Buisson N; Dalmas AF; Bruneau B; Dahmani S
    Anaesth Crit Care Pain Med; 2019 Oct; 38(5):535. PubMed ID: 30807880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.